SYNTHESIS AND IN SILICO ANALYSIS OF 3-(1-(3-TOLYL)THIOUREIDO)PROPANOIC ACID DERIVATIVES AS ARACHIDONIC ACID METABOLIC PATHWAY INHIBITORS

Simonas Gruodis1, Kazimieras Anuseivičius1, Birutė Grybaitė1, Ilona Jonuškienė1, Birutė SapijanskaitėBanevič1, Vytautas Mickevičius1

1 Kaunas University of Technology

Arachidonic acid metabolism to leukotrienes catalysed by 5-lipoxygenase (5-LOX) inhibition is a potential target for inflammation modulation [1]. Molecular docking is an important component of drug discovery process. It is the most common computional structure-based drug desing method and has been widely used since 1980s [2]. This process allows researchers to screen large databases of theoretical compounds which can be focused down and then tested experimentaly. Molecular docking comprises of two separate algorithms. Sampling algorithm predicts confirmations which ligand can assume in the active pocket. And a scoring function which predicts binding energy between ligand and an anctive pocket [3].

Figure 1
Fig. 1. Synthesis of novel 3-(1-(3-tolyl)thioureido)propanoic acid derivatives
Results.

Arachidonic acid metabolism can be inhibited by thiazole moiety containing compounds [4-6]. New thiazole derivatives 2-10 were synthesized by cyclocondensation reactions with a-halogenketones as shown in Fig. 1. All computational work was done on MOE [7] following procedure adapted from reported protocol [8] with slight modification. Synthesised compounds 2-10 showed competitive inhibition of 5-lipoxygenase.


[1] Rådmark, O. Et al. Trends Biochem Sci 32, 332-341 (2007).

[2] Stanzione, F. Et al. Prog Med Chem 60, 273-343 (2021).

[3] Berry, M. Et al. 487-502 (2015).

[4] Liaras, K. Et al. Molecules 23, 685-707 (2018).

[5] Sinha, S. Et al. Bioorg Med Chem 27, 3745-3759 (2018).

[6] Jacob P, J. Et al. Bioorg Chem 100, 103882 (2020).

[7] Molecular Operating Environment (MOE), H3A 2R7, (2022).

[8] Chen, F. et al. Nat Metab 4, 534-546 (2022).